Xortx Therapeutics Inc
(XRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,849 | -3,019 | -2,158 | -4,857 | -3,524 |
| Depreciation Amortization | 65 | 32 | 140 | 115 | 99 |
| Accounts receivable | 38 | 30 | 21 | 14 | 51 |
| Other Working Capital | 332 | -327 | -1,031 | -619 | -841 |
| Other Operating Activity | 373 | 1,980 | -3,555 | 62 | 0 |
| Operating Cash Flow | $-2,040 | $-1,304 | $-6,583 | $-5,285 | $-4,214 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -4 | -4 | -4 |
| Purchase Sale Intangibles | -12 | -3 | -42 | -32 | -25 |
| Other Investing Activity | -12 | -3 | -42 | -32 | -25 |
| Investing Cash Flow | $-12 | $-3 | $-46 | $-37 | $-29 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,017 | 2,017 | 0 | 0 | 0 |
| Other Financing Activity | -322 | -314 | -361 | -49 | -32 |
| Financing Cash Flow | $1,695 | $1,704 | $-361 | $-49 | $-32 |
| Exchange Rate Effect | -12 | -9 | 4 | 6 | 6 |
| Beginning Cash Position | 3,448 | 3,448 | 10,434 | 10,434 | 10,434 |
| End Cash Position | 3,079 | 3,835 | 3,448 | 5,069 | 6,164 |
| Net Cash Flow | $-369 | $388 | $-6,987 | $-5,365 | $-4,270 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,040 | -1,304 | -6,583 | -5,285 | -4,214 |
| Capital Expenditure | N/A | N/A | -4 | -4 | -4 |
| Free Cash Flow | -2,040 | -1,304 | -6,588 | -5,289 | -4,219 |